Enter Details

Comment on stories, receive email newsletters & alerts.

This is your permanent identity for Business Insider Australia
Your email must be valid for account activation
Minimum of 8 standard keyboard characters


Email newsletters but will contain a brief summary of our top stories and news alerts.

Forgotten Password

Enter Details

Back to log in

Tagged With Pharmaceutical

DIGITAL HEALTH BRIEFING: Top trends from HealthConf 2017 -- FDA set to change genetic health risk test regulations -- Australia strengthens digital health record system

Wall Street's most hated drugmaker is getting annihilated after a bizarre conference call

Amazon is making noise in pharma these days -- here's what it could all mean

A furious employee is suing Wall Street's most hated pharma stock over claims about its blockbuster drug

A furious employee is suing drugmaker Mallinckrodt over claims about its $38,000-a-dose blockbuster

Explosive leaked audio reveals the moment a drug company lied about a patient having cancer to get them opioids

Mallinckrodt is getting crushed after a judge invalidated many of its patents

A popular herbal supplement can interfere with many medications, including birth control

Shares in drug maker Indivior tanked almost 40% after losing its heroin treatment copyright case

ANALYST: Most investors respect the Merck CEO's decision to resign from Trump's council

Things are finally really starting to hurt for the maker of EpiPen

One of Trump's best sounding proposals to control drug pricing is a total dud

There's frightening new data on the effects of a blockbuster drug Wall Street loves to hate

Donald Trump just sold us all out on drug pricing

Check out how the shorts have been piling into Wall Street's most hated pharma stock

A Wall Street investor call revealed part of the secret of why drugs are so expensive

States are starting to stand up to 'the new Big Tobacco' because Washington won't

It sounds like the maker of EpiPen is freaking out ahead of a big shareholder meeting

One of the most hated drug companies on Wall Street is facing another nasty probe

Amazon has several hurdles to jump before it could enter pharmaceuticals